Mr. Teng Ling: Born in June 1981, Chinese nationality, doctoral degree. From April 2011 to March 2013, he served as R&D scientist of Changzhou Adam Biotechnology Co., LTD. From April 2013 to May 2021, he served as senior scientist of Guangzhou Bioseal Biotechnology Co., LTD. From June 2021 until now, he has been the vice general manager of the company. Mr. Teng Ling has been committed to the field of biomedical technology for a long time, and has rich research experience in the design and development of transgenic carriers, monoclonal antibody drugs and the development of new hemostatic products. He has completed technical optimization and several prototype product development. He has published 3 papers in PLoS One, ell Biol Int and other journals, and has obtained 2 invention patents of the World Intellectual Property Organization, 1 invention patent of the United States, and 8 invention patents and utility model patents of China.